LPL Financial’s KALA BIO KALA Stock Holding History

LPL Financial’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-345	Closed	-$2.98K	–	6287
2026 Q1	$2.98K	Buy	+345	New	+$7.3K	﹤0.01%	5956
2022 Q2	–	Sell	-7	Closed	-$24K	–	4490
2022 Q1	$24K	Hold	7	–	–	﹤0.01%	4110
2021 Q4	$20K	Hold	7	–	–	﹤0.01%	4291
2021 Q3	$46K	Buy	+7	New	+$60.4K	﹤0.01%	4233

Other funds holding KALA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

LPL Financial's KALA Position: Q2 2026 in Review

LPL Financial sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 345 shares — an estimated $2.98K sold.

LPL Financial first reported a position in KALA in Q3 2021 and held it in 4 quarters. The position peaked at $46K in Q3 2021. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

LPL Financial reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
LPL Financial sold 345 KALA BIO shares in Q2 2026, an estimated $2.98K.
LPL Financial first reported a position in KALA BIO in Q3 2021 and held it in 4 quarters.
LPL Financial's KALA BIO position peaked at $46K in Q3 2021.
14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.